International Advisory Board

International Advisory Board

Demonstration profiles only — fictional names and proposed disciplinary representation.

The International Advisory Board is intended to provide strategic scientific guidance, contribute independent academic perspectives, and support the journal's engagement with the international pharmaceutical research community.

Proposed Advisory Positions

Dr. Michael R. Ashford, PhD
Advisory Area: Advanced Pharmaceutical Formulation and Drug Delivery

Institutional affiliation: Pending verification.

Dr. Isabella C. Morelven, PhD
Advisory Area: Pharmaceutical Chemistry and Molecular Drug Design

Institutional affiliation: Pending verification.

Dr. Kenji R. Takemori, PhD
Advisory Area: Pharmaceutical Biotechnology and Biopharmaceutical Research

Institutional affiliation: Pending verification.

Dr. Amira S. Elmareth, PhD
Advisory Area: Pharmacology, Toxicology, and Therapeutic Innovation

Institutional affiliation: Pending verification.

Dr. Lucas M. Ferrevan, PhD
Advisory Area: Clinical Pharmacy and Translational Pharmaceutical Sciences

Institutional affiliation: Pending verification.

Advisory Responsibilities

The International Advisory Board provides recommendations concerning the journal's scientific development, scope refinement, research priorities, and adherence to recognized international publishing standards.

Advisory members may assist in identifying emerging scientific directions, recommending qualified specialists, and strengthening the journal's international scholarly engagement.

Advisory membership does not automatically confer authority over individual manuscript decisions. Such responsibilities must be formally defined within the journal's editorial governance framework.